Ye Ji Jang

Title: Ye Ji Jang: Innovator in Pathological Angiogenesis

Introduction

Ye Ji Jang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the area of pathological angiogenesis. With a total of two patents to his name, Jang's work focuses on innovative methods to combat various diseases.

Latest Patents

Ye Ji Jang's latest patents include methods of inhibiting pathological angiogenesis with doppel-targeting molecules. These patents describe doppel-targeting molecules that are useful for inhibiting pathological angiogenesis and treating diseases associated with this condition. Such diseases include tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (PAH), and neoplasms. The patents also detail methods for detecting doppel expression in a subject, along with related compositions and methods.

Career Highlights

Throughout his career, Ye Ji Jang has worked with prestigious institutions such as Seoul National University and the University of Ulsan. His research has contributed to advancements in understanding and treating conditions related to pathological angiogenesis.

Collaborations

Some of Ye Ji Jang's notable coworkers include Youngro Byun and In San Kim. Their collaborative efforts have furthered research in the field and enhanced the impact of their findings.

Conclusion

Ye Ji Jang's innovative work in the field of pathological angiogenesis showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to addressing critical health challenges through research and innovation.